The debate on personalized genetic testing

An estimated 848, 000 men and 790,000 women will be diagnosed with some form of cancer this year according to the American Cancer Society.  New genetic sequencing technologies have made it possible to get personalized genetic tests to determine one’s risk for developing a disease, including many different types of cancers.  The goal of genetic testing is to utilize the results that may indicate the presence of a disease-associated gene mutation to determine appropriate preventative care or targeted treatments.

So why have experts from the American College of Obstetricians and Gynecologists  (ACOG) recommended against individuals using such technologies to provide answers about their personal genetic risks? To read more, visit the Oncofertility Consortium blogsite.